Acknowledgements Funding No funding or sponsorship was received for this study or publication of this article
By improving metabolic health and supporting safe weight management solutions, this therapy contributes to overall wellness and reduces the risk of chronic diseases
Major challenges confronting the future of GLP-1 receptor agonists is their cost and accessibility
Compared to BPC-157, which acts primarily via the nitric oxide and growth hormone receptor pathways, and TB-500, which functions through actin sequestration and VEGF signalling, GHK-Cu operates largely through copper-mediated gene expression modulation and extracellular matrix remodelling
This therapy aims to support nervous system function, reduce anxiety, and restore overall well-being
Month 2 (weeks 5-8) demands cold foods over hot, BRAT diet during worst days, and aggressive nausea management through strategic meal timing